The methylation levels of eight genes (CALCA, HOXA9, RASSF1A, CDKN2A, DLEC1, CDH13, PITX2, and WT1) in ctDNA were significantly higher in lung cancer patients than in non-lung cancer patients. This evidence concerns the gene CDKN2A and lung carcinoma.